A detailed history of Gamma Investing LLC transactions in Care Dx, Inc. stock. As of the latest transaction made, Gamma Investing LLC holds 2,379 shares of CDNA stock, worth $50,363. This represents 0.01% of its overall portfolio holdings.

Number of Shares
2,379
Previous 2,210 7.65%
Holding current value
$50,363
Previous $34.3 Million 116.44%
% of portfolio
0.01%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 04, 2024

BUY
$14.41 - $33.99 $2,435 - $5,744
169 Added 7.65%
2,379 $74.3 Million
Q2 2024

Jul 02, 2024

BUY
$7.56 - $16.15 $15,218 - $32,509
2,013 Added 1021.83%
2,210 $34.3 Million
Q1 2024

Apr 05, 2024

BUY
$7.96 - $12.37 $342 - $531
43 Added 27.92%
197 $2.09 Million
Q4 2023

Feb 01, 2024

BUY
$4.9 - $12.86 $754 - $1,980
154 New
154 $1.32 Million

Others Institutions Holding CDNA

About CareDx, Inc.


  • Ticker CDNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 53,458,100
  • Market Cap $1.13B
  • Description
  • CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...
More about CDNA
Track This Portfolio

Track Gamma Investing LLC Portfolio

Follow Gamma Investing LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gamma Investing LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gamma Investing LLC with notifications on news.